miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
S Liu, Q Wang, Y Liu, ZY Xia - Journal of biosciences, 2019 - Springer
Prostate cancer (PCa) represents the most frequently diagnosed cancer in men. Cisplatin,
also known as cis-diamminedichloroplatinum (DDP), is a standard chemotherapeutic agent …
also known as cis-diamminedichloroplatinum (DDP), is a standard chemotherapeutic agent …
[HTML][HTML] Effect of ABC transporter expression and mutational status on survival rates of cancer patients
O Kadioglu, MEM Saeed, M Munder, A Spuller… - Biomedicine & …, 2020 - Elsevier
ATP-binding cassette (ABC) transporters mediate multidrug resistance in cancer. In contrast
to DNA single nucleotide polymorphisms in normal tissues, the role of mutations in tumors is …
to DNA single nucleotide polymorphisms in normal tissues, the role of mutations in tumors is …
[HTML][HTML] Relationship between gene polymorphisms and prostate cancer risk
QH Han, ZJ Shan, JT Hu, N Zhang, XP Zhang - Asian Pacific Journal of …, 2015 - Elsevier
Objective To investigate the relationship between genetic factor and prostate cancer (Pca)
risk and the possible cause in it. Methods The polymorphisms of cytochrome P450 family 17 …
risk and the possible cause in it. Methods The polymorphisms of cytochrome P450 family 17 …
[PDF][PDF] Association of ABCB1 C3435T and C1236T gene polymorphisms with the susceptibility to acute myeloid leukemia in a Chinese population
J Li, C Yang, W Wanling, H Xiaolin, S Ling - Int. J. Clin. Exp. Pathol, 2016 - e-century.us
We conducted a case-control study to investigate the role of ABCB1 C3435T (rs1045642)
and C1236T (rs1128503) gene polymorphisms in the susceptibility to acute myeloid …
and C1236T (rs1128503) gene polymorphisms in the susceptibility to acute myeloid …
[PDF][PDF] Exploration of a xenograft model of human prostate cancer to predict patient treatment response
R Beekharry - 2014 - hull-repository.worktribe.com
For several years, docetaxel was the only treatment to improve survival of patients with
metastatic prostate cancer. There are now many novel agents available but the optimal …
metastatic prostate cancer. There are now many novel agents available but the optimal …